Mayo Clinic Talks

Host: Darryl S. Chutka, M.D. [@chutkaMD] Guest: Eric J. Olson, M.D. It’s estimated that about 30 million people in the U.S. have sleep apnea and the worldwide prevalence is approaching 1 billion. The traditional treatment is continuous positive airway pressure or CPAP which is quite effective and used to enhance ventilation. Unfortunately, there are a significant number of patients with sleep apnea who can’t tolerate CPAP. This may result in an untreated patient, increasing their risks to a variety of potentially serious complications. How do we manage the CPAP-intolerant patient? What else is available for the patient with sleep apnea? Which patients are candidates for these alternative treatments and how effective are they? In this podcast, we’ll discuss these questions and more with our guest, sleep expert Eric J. Olson, M.D., from the Division of Pulmonary and Critical Care at the Mayo Clinic. Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Host: Darryl S. Chutka, M.D. [@chutkaMD] Guest: Michael H. Silber, M.B., Ch.B. Depending on the patient, a complaint of feeling tired, fatigued or sleepy may all mean the same thing. In others they may not feel that sleepiness is the same as fatigue or tiredness. Once we sort out what the patient is actually describing, how do we evaluate the sleepy patient? How much sleep do we need per night and what’s an inadequate amount of sleep? How do we evaluate the quality of a patient’s sleep and what role does age play in the evaluation of a patient’s sleep? These are questions we’ll discuss with our guest for this podcast, Michael H. Silber, M.B., Ch.B., a neurologist and sleep expert at the Mayo Clinic. Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Host: Darryl S. Chutka, M.D. [@chutkaMD] Guest: Michael D. Leise, M.D. The liver is the second-most transplanted organ; nearly 10,000 patients received a liver transplant in 2021. The major factor, which has limited the transplants performed, has been the availability of the donated organs and some patients have waited several years before an acceptable organ becomes available. Transplants can be performed for a variety of end-stage liver diseases, usually giving patients years of additional life. Who’s a candidate for a liver transplant and what criteria for selection are required? Our topic for this podcast is “Liver Transplant Selection Criteria” and we’ll discuss this topic with our guest, Michael D. Leise, M.D., from the Division of Gastroenterology and Hepatology at the Mayo Clinic. Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Host: Darryl S. Chutka, M.D. [@chutkaMD] Guest: Samy M. Riad, M.D. Kidney transplants are quite common; over 20,000 transplants will have been performed by the end of 2022 and there are currently just under 90,000 individuals on the national transplant waiting list. They’ve been remarkably successful in giving patients with renal failure an improved quality of life. However, patients who have had kidney transplants have unique medical needs. Since most transplant patients will return to their primary care providers for the majority of their ongoing care, what important information do we need to successfully care for these patients? What unique medical needs do they have? And what potential health problems are more commonly seen in transplant patients? In this podcast, our guest, Samy M. Riad, M.D., a nephrologist at the Mayo Clinic will answer these questions and more as we discuss the management of the post-renal transplant patient. Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Host: Darryl S. Chutka, M.D. [@chutkaMD] Guest: Scott M. Cheney, M.D. Except for skin cancer, prostate cancer is the most common malignancy in males. 1 in 8 men will be diagnosed with prostate cancer during his lifetime, most over the age of 65. If diagnosed early, treatment is quite effective and results in a very favorable survival rate. Several very effective treatment options are now available for patients. In this podcast, we’ll discuss the various treatments and what patients can expect following each option. We’ll review how a post-prostate cancer patient should be followed by their primary care provider and when there might be reason for concern of a recurrence. The guest for this podcast is Scott M. Cheney, M.D., a urologist from the Mayo Clinic in Phoenix, Arizona. This episode is brought to you by: Astellas Oncology | https://astellasoncology.com/ Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Host: Darryl S. Chutka, M.D. [@chutkaMD] Guest: Alan H. Bryce, M.D. Prostate cancer is the second most common malignancy in men, second only to skin cancer and due to increased efforts in screening, most prostate cancers are found very early, and these men have an excellent survival rate. Unfortunately, a percentage of men develop an advanced prostate cancer and the disease becomes much more aggressive with significantly lower survival rates. Who’s at risk for advanced prostate cancer? How does the survival rate change with metastatic disease? Finally, what are the various treatment options and how effective are they? In this podcast, we’ll discuss these questions with our guest, Alan H. Bryce, M.D., from the Division of Hematology and Oncology at the Mayo Clinic. This episode is brought to you by: Astellas Oncology | https://astellasoncology.com/ Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Host: Darryl S. Chutka, M.D. [@chutkaMD] Guest: Nahid Punjani, M.D., M.P.H. Issues related to the prostate can play a significant role in a man’s sexual function. We commonly use medications for benign prostate problems such as BPH which can produce adverse effects. It’s also very common for the treatment of prostate cancer, whether we use radiation therapy, surgical prostatectomy, or hormonal therapy to cause sexual dysfunction. In this podcast, we’ll review the important role the prostate plays in sexual function as we discuss the “Prostate and Sexual Health” with our guest, Nahid Punjani, M.D., M.P.H., a urologist at the Mayo Clinic. This episode is brought to you by: Astellas Oncology | https://astellasoncology.com/ Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Host: Darryl S. Chutka, M.D. [@chutkaMD] Guest: R. Jeffrey Karnes, M.D. Prostate cancer is the most common solid organ malignancy in males, and it’s estimated that 1 in 8 men will develop prostate cancer during their lifetime. When diagnosed early, it has an excellent survival rate with a variety of very effective treatment options. What are the advantages and disadvantages of each? Why would one option be chosen over another and how do the adverse effects of the various treatments differ? In this podcast, I’ll be discussing these questions with our guest, R. Jeffrey Karnes, M.D., a urologist at the Mayo Clinic. This episode is brought to you by: Astellas Oncology | https://astellasoncology.com/ Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Host: Darryl S. Chutka, M.D. [@chutkaMD] Guest: Daniel M. Frendl, M.D., Ph.D. Prostate cancer is one of the most common malignancies in men, second only to skin cancer. It’s estimated that 1 in 8 men will develop prostate cancer during their lifetime. The predominant screening test for prostate cancer has been the prostate specific antigen or PSA. However, there has been some controversy surrounding the use of PSA. It’s an easily administered test, it’s relatively inexpensive and it’s capable of identifying men with possible prostate cancer. So, what’s the controversy? Is the PSA an effective screening test? Who should be tested and how have urologists modified their practice to manage patients with an elevated PSA? We’ll discuss these questions in today’s podcast on “Screening for Prostate Cancer” with our guest, Daniel M. Frendl, M.D., Ph.D., a urologist at the Mayo Clinic. This episode is brought to you by: Astellas Oncology | https://astellasoncology.com/ Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Host: Darryl S. Chutka, M.D. [@chutkaMD] Guest: Mitchell R. Humphreys, M.D. Benign prostatic hyperplasia or BPH is quite common in middle-age and older men. It’s estimated that up to 70% of men over age 60 have symptoms from BPH. While BPH is not a life-threatening condition, it does produce symptoms which can negatively affect the lifestyle of our patients. Since most of the patients with BPH are managed by primary care providers, we should be comfortable with the variety of treatment options available. When should treatment be initiated? What’s available pharmacologically? And when should a urologist be consulted to consider a surgical option? In this podcast, we’ll discuss these questions and more with Mitchell R. Humphreys, M.D., from the Department of Urology at the Mayo Clinic. This episode is brought to you by: Astellas Oncology | https://astellasoncology.com/ Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Host: Darryl S. Chutka, M.D. [@chutkaMD] Guest: Colin P. West, M.D., Ph.D. The practice of medicine is often stressful and at times, even frustrating. Sometimes the stress and frustration can get out of hand and lead us to feeling overwhelmed and hopeless. This has been described as burnout. There’s good evidence to suggest that well over half of all physicians practicing in the U.S. have exhibited some symptoms of burnout at some time during their career. Healthcare professional burnout not only has negative consequences for the clinician, but also for patients, as patient care can often suffer. What are the symptoms of burnout, can we prevent them and how can we manage those who are experiencing professional burnout? We’ll discuss these questions and more with Colin P. West, M.D., Ph.D., an internist in the Division of General Internal Medicine at the Mayo Clinic. Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Host: Darryl S. Chutka, M.D. [@chutkaMD] Guest: Tara Schmidt, MEd, RDN, LD Nutrition is so important to our health. What and how much we eat can help keep us healthy or increase our risk of developing a number of health problems including cardiovascular disease, diabetes, malignancy or a variety of degenerative health conditions. Unfortunately, many of our patients obtain their information regarding nutrition from the media which is often very inaccurate. It’s our responsibility as primary care providers to assess our patients’ nutritional status and give them accurate recommendations regarding dietary changes they should make in order to remain healthy. This starts with a nutritional history. Yet very few of us have had any formal education in nutrition. How do we take a nutritional history? What are the important questions to ask? We’ll discuss this and other nutritional issues with our guest for this podcast, Tara Schmidt, MEd, RDN, LD, a registered dietician at the Mayo Clinic. Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Host: Darryl S. Chutka, M.D. [@chutkaMD] Guest: Thom W. Rooke, M.D. Today, we’re excited to bring back a special lecture by popular demand from Season 1 of Mayo Clinic Talks Podcast. We’ll be discussing varicose veins and venous insufficiency with Thom W. Rooke, M.D., from Cardiovascular Medicine at the Mayo Clinic. Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Host: Darryl S. Chutka, M.D. [@chutkaMD] Guest: Eoin Flanagan, M.B., B.Ch. Nearly 1 million individuals in the U.S. have multiple sclerosis. Most acquire the disease between the ages of 20 and 50. It’s often difficult to establish a diagnosis as the symptoms can be vague and often vary significantly from one individual to another. The disease can be very frightening, often debilitating, and progressive; up until recently, we’ve had very little to offer patients in the way of treatment. However, in the past few years there have been numerous advances in treatment options which have given hope to the many patients with MS. We’ll be discussing multiple sclerosis in this podcast. Our guest is Eoin Flanagan, M.B., B.Ch., a neurologist from the Department of Neurology at the Mayo Clinic. Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Host: Darryl S. Chutka, M.D. [@chutkaMD] Guest: Andrew C. Storm, M.D. Determining the source of GI blood loss can be a challenging dilemma. On occasion, we have clues regarding where we should start looking, but in some cases, no such clues exist. It’s best to use a stepwise approach to determining the source and in most cases, this will give us the answer we need. When a cause is found, most tend to be from an upper GI source rather than the colon. Whereas an upper endoscopy and colonoscopy will determine the source in the majority, in some cases, more aggressive techniques are required. In this podcast, we’ll be discussing GI blood loss, and which approach we should use to determine the source. Our guest is Andrew C. Storm, M.D., a gastroenterologist from the Division of Gastroenterology and Hepatology at the Mayo Clinic. Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Host: Darryl S. Chutka, M.D. [@chutkaMD] Guest: Greg A. Poland, M.D. [@drgregpoland] Severe acute respiratory syndrome coronavirus 2, also known as COVID-19, is a novel virus with a rapidly changing genotype. It’s responsible for over a million deaths so far. One of every 300 Americans have died as a result of the virus and infection with COVID-19, and it has been responsible for a reduction in life expectancy in the U.S. for both 2021 and 2022. There are 4 widely available, approved vaccines in the United States, yet an inadequate number of individuals have been immunized and very few are still wearing protective masks. The consequences of this include continued excess morbidity and mortality as well as the development of a variety of new variants of the virus. Our guest for this podcast is Greg A. Poland, M.D., an internist, and the director of vaccine research at the Mayo Clinic. He’s also the lead author of an article published in Mayo Clinic Proceedings in December 2022. The article is entitled “Year 3 of COVID-19: Harsh Truths, Brutal Realities and Glimmers of Hope”. We’ll be discussing some of the key points from this article. Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Host: Darryl S. Chutka, M.D. [@chutkaMD] Guest: Daniel L. Hurley, M.D. Today we’re excited to bring back a special lecture by popular demand from Season 1 of Mayo Clinic Talks Podcast. Today we’re joined by Daniel L. Hurley, M.D., a Mayo Clinic Endocrinologist and heavily awarded educator and practitioner. Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Host: Darryl S. Chutka, M.D. [@chutkaMD;] Guest: Alexander S. Niven, M.D. Pulmonary function tests are extremely useful in both diagnosing and managing patients with respiratory disease. In addition to a medical history, physical exam and imaging studies, they give us a great deal of information of the pulmonary physiology and help us understand why patients have various respiratory symptoms. However, there are quite a number of pulmonary function tests available to us and which tests we should order can be confusing. Do we know when spirometry, lung volumes or diffusion capacity will be useful for evaluating the various pulmonary conditions? Our guest for this podcast is Alexander S. Niven, M.D., from the Division of Pulmonary and Critical Care Medicine at the Mayo Clinic and he’ll provide answers to these questions and more as we discuss “How to Use Pulmonary Function Tests Effectively”. Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Guest: Ekta Kapoor, M.B.B.S. Host: Darryl S. Chutka, M.D. [@chutkaMD] Obesity is becoming a serious epidemic in the United States, and it’s estimated that if current trends continue, by 2030 nearly half of all adults in the U.S. will be obese. Prevalence rates of obesity are steadily increasing in both men and women and some of the highest rates are seen in post-menopausal women. Obesity carries an increased risk for a variety of medical conditions and death rates of several types of cancer increase in obese women. The topic for this podcast is obesity in women and our guest is women’s health expert, Ekta Kapoor, M.B.B.S., from the Mayo Clinic. We’ll discuss reasons women tend to develop obesity in middle age, the risks associated with the type of obesity that occurs following menopause and effective strategies to manage weight gain with aging in women. Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Host: Darryl S. Chutka, M.D. [@chutkaMD] Guest: Donald D. Hensrud, M.D., M.S. Today we’re excited to bring back a special lecture by popular demand from Season 1 of the Mayo Clinic Talks Podcast. Darryl S. Chutka, M.D., a general internist at Mayo Clinic in Rochester, Minnesota, and Donald D. Hensrud, M.D., M.S., a physician in Preventative Medicine & the Medical Director for the Mayo Clinic Healthy Living Program discusses the risks and benefits of drinking coffee. Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Host: Sanjeev (Sanj) Kakar, M.D., [@sanjkakar] Guest: Michael J. Ackerman, M.D., Ph.D. Guest: Thomas M. Munger, M.D. Much attention has been paid to sudden cardiac arrest in athletes. Did you know the likelihood of sudden cardiac arrest in high school athletes is between 1 in 50,000 to 1 in 80,000 and for college-aged players, the risk is estimated at 1 in 13,426. Among National Collegiate Athletic Association (NCAA) athletes, there is an increased risk in those who are male, of black race and play basketball. In this podcast, we discuss what the causes of sudden cardiac arrest are, the role of screening protocols and what can be done in patients who experience this event with cardiology experts Tom M. Munger, M.D., and Michael J. Ackerman, M.D., Ph.D. SPECIAL EPISODE: https://ce.mayo.edu/content/mayo-clinic-talks-podcasts-special-episode-sudden-cardiac-arrest-athletes Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Host: Darryl S. Chutka, M.D. [@chutkaMD] Guest: Mairead M. Bartley, M.B., B.Ch., B.A.O. Dementia is a devastating health condition for patients, their families, and a challenging disease for primary care providers. Whereas the diagnosis is usually straightforward to establish, the pharmacologic treatment options have been, at best, disappointing. With little to nothing to offer our patients which would improve their cognitive status; our responsibility for their management doesn’t end there. We still have a responsibility to provide ongoing care to these patients as well as their caregivers as they progress into the later stages of dementia. This brings up numerous management challenges including maintaining our patient’s independence, as well as numerous safety and nutrition issues. This podcast will review the management of the patient with later stage dementia with our guest is Mairead M. Bartley, M.B., B.Ch., B.A.O., a geriatrician and internist in the Division of Community Medicine at the Mayo Clinic. Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Host: Darryl S. Chutka, M.D. [@ChutkaMD] Guest: Stephen Kopecky, M.D. [@DrSteveKopecky] Hyperlipidemia is extremely common in the U.S., and we have a variety of pharmacologic agents which are very effective in treating this condition and improving our patients’ lipid profile. Yet there are patients who have elevated lipids but may not meet the criteria for pharmacologic therapy and other patients who don’t tolerate the medications we commonly prescribe. What are the alternative treatments available for managing hyperlipidemia and how effective are they? How do they compare with pharmacologic therapy? We’ll discuss these issues and more in this podcast with our guest, preventive cardiologist Stephen Kopecky, M.D., from the Mayo Clinic. Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Host: Darryl S. Chutka, M.D. [@chutkaMD] Guest: Sanjeev (Sanj) Kakar, M.D. [@sanjkakar] The hand and wrist are very complex parts of our anatomy and composed of multiple tendons, muscles, and nerves. The hand also contains over 30 bones. Hand or wrist complaints are some of the more common reasons patients come to their primary care provider, and at times, the cause can be quite elusive. We need to be able to accurately assess the patient’s symptoms, diagnose the various disorders and determine which ones need to be referred for specialty care and which ones we can manage on our own. In this podcast, we’ll discuss some of the most common hand and wrist disorders with Sanjeev Kakar, M.D., a hand specialist from the Department of Orthopedics at the Mayo Clinic. Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Host: Darryl S. Chutka, M.D. [@chutkaMD] Guest: Mira T. Keddis, M.D. [@keddis_mira] Chronic kidney disease can have a major impact on a patient’s quality of life; reducing their energy level, impacting their diet and may limit medications or alter medication dosages we prescribe. It’s estimated that kidney disease affects nearly 40 million people in the U.S. or 15% of the population, and two out of five adults with severe kidney disease don’t even know they have it. As primary care providers, we need to know how to prevent kidney disease, how we assess renal function and how to manage those with moderate to severe renal impairment. Our guest for today’s podcast is Mira T. Keddis, M.D., a nephrologist at the Mayo Clinic in Scottsdale, Arizona. Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Guest: Cheryl L. Khanna, M.D. Host: Darryl S. Chutka, M.D. [@chutkaMD] Glaucoma is a very common eye disease affecting more than 70 million people worldwide and it’s a leading cause of blindness, accounting for over 12% of blindness around the world. While it tends to be more common in older individuals, it can occur in younger patients as well. There are a variety of types of glaucoma as well as several new treatment options available. In this podcast, we’ll discuss the various types of glaucoma, its treatment options and what we should do as primary care providers to help patients get a proper diagnosis and prevent the vision loss which can be associated with glaucoma. Our guest is Cheryl L. Khanna, M.D., an ophthalmologic surgeon at the Mayo Clinic. Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Guest: Regan N. Theiler, M.D., Ph.D. Host: Darryl S. Chutka, M.D. @chutkaMD Abortion is a common procedure. three out of ten pregnancies and six out of ten unintended pregnancies end with an induced abortion. Overall, about one in four women in the U.S. will have an abortion by the age of 45 years. The U.S. Supreme Court’s June 2022 ruling to overturn Roe vs. Wade has shifted the legal battle over abortion to the states, resulting in some states prohibiting abortion and others moving to safeguard it. The topic for this podcast is abortion and what the primary care provider should know. Our guest is Regan N. Theiler, M.D., Ph.D., from the Department of Obstetrics and Gynecology at the Mayo Clinic. Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. Faculty Twitter: [@chutkaMD; https://twitter.com/ChutkaMD]

Host: Darryl S. Chutka, M.D. [@chutkaMD] Guest: Robert M. Jacobson, M.D. [@RobertJMD] Immunizations are one of the greatest success stories in modern medicine and it’s estimated that they’ve saved more lives and prevented more disabilities than any other medical intervention. They’re probably responsible, more than any other medical advance, in contributing to our increased longevity as a population. They’re also extremely cost-effective and their benefits far outweigh the very small risks they carry. This podcast will review new information regarding immunizations and how we as clinicians can increase our patients’ immunization rates. Our guest is Robert M. Jacobson, M.D., a pediatrician, and expert in immunizations from the Department of Pediatrics at the Mayo Clinic. Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. Faculty Twitter: [@chutkaMD; https://twitter.com/ChutkaMD] [@RobertJMD; https://twitter.com/robertjmd]

Guest: Matthew J. Ferber, Ph.D. Host: Darryl S. Chutka, M.D. [@chutkaMD] Over the past decade or so, we’ve learned a great deal about the human genome, and this has allowed us to determine which medical conditions our patients are at an increased risk of developing and which medications may be best suited for their medical problems. In addition to the clinical genetic tests we use in our practice, direct to consumer home genetic testing has become extremely popular. This podcast will review home genetic testing and what information patients can expect with these tests, whether the information they receive is accurate and how home genetic testing differs from the genetic tests we order. Our guest is Matthew J. Ferber, Ph.D., a clinical molecular geneticist at the Mayo Clinic. Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Host: Darryl S. Chutka, M.D. (@chutkaMD) https://twitter.com/ChutkaMD Guest: Kurt A. Kennel, M.D. Hip fractures have had a major impact on our healthcare system with an economic burden estimated to be over $20 billion per year. Due to the increasing age of our population, they’ll have an even greater impact in the future. In addition to the economic burden, hip fractures often result in major changes to one’s lifestyle. As a result, the detection, prevention and management of osteoporosis becomes an important health strategy. The topic for this podcast is osteoporosis and our guest is Kurt A. Kennel, MD., a Mayo Clinic Endocrinologist, and specialist in bone metabolism. Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Guest: Pritish K. Tosh, M.D. (@DrPritishTosh) Host: Darryl S. Chutka, M.D. (@chutkaMD) The COVID-19 pandemic exposed the vulnerability of the medical product supply chain and its impact on providing optimal healthcare. The spread of the disease was accompanied by not only shortages of personal protective equipment but also medications and many other products we depend on every day in our clinical practice. We’ve learned that we cannot provide adequate or timely health care when there are shortages of important products. As a result, the health of our patients and healthcare providers has been endangered. It’s also resulted in a rationing of care and an increased risk of error as we’re forced to use sub-standard or replacement products. It’s caused us to look for new solutions to reduce our medical supply chain vulnerabilities. Our guest for this podcast is Pritish K. Tosh, M.D., an infectious disease specialist at the Mayo Clinic. Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. Twitter Handles: (@chutkaMD); https://twitter.com/ChutkaMD (@DrPritishTosh); https://twitter.com/drpritishtosh

Guest: John B. Kisiel, M.D. (@DrJohnKisiel) Host: Darryl S. Chutka, M.D. (@chutkaMD) Colon polyps are relatively common in our population and, in most cases, are relatively easily found and removed, thereby reducing one's risk of developing colorectal cancer. What are the various types of colon polyps and which polyps have a greater tendency to become malignant? How long does it take a polyp to develop into colon cancer and how often does colonoscopy miss polyps? These are just some of the topics we’ll discuss in today’s podcast. Our guest is John B. Kisiel, M.D., a gastroenterologist at the Mayo Clinic. Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Host: Denise M. Dupras, M.D., Ph.D. Guest: Andres J. Acosta, M.D., Ph.D. (@dr_aac) The obesity epidemic continues to escalate in the United States and obesity rates are increasing around the world. It is estimated that by 2030, 50% of adults and 25% of children worldwide will be obese. Patients are the interaction of their genetics and environment; this episode explores the importance of understanding the mechanisms behind food intake regulation and weight to develop individualized therapies to treat obesity. Our guest for this episode is Andres J. Acosta, M.D., Ph.D., a physician-scientist at Mayo Clinic in Rochester, Minnesota. He is also an assistant professor of medicine at Mayo Clinic College of Medicine and Science, and principal investigator of the Precision Medicine for Obesity Laboratory.

Guest: Elizabeth (Ebbie) A. Stewart, M.D. Host: Darryl S. Chutka, M.D. Uterine fibroids are the most common tumor of the female reproductive tract and women who are approaching menopause are at greatest risk for having them. In most cases, they don’t produce symptoms and only a minority of women require treatment. The topic for this podcast is uterine fibroids and we’ll discuss how fibroids can be diagnosed, their most common symptoms, who requires treatment and some of the latest treatment options with our guest, Elizabeth A. Stewart, M.D., from the Department of Obstetrics and Gynecology at the Mayo Clinic. Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Guest: Alexandre Gaspar Maia, Ph.D. (@gasparma1a) Host: Denise M. Dupras, M.D., Ph.D. Epigenomics is a fascinating field in which researchers chart the locations and understand the functions of all chemical tags that mark the genome. The epigenome is the first boundary from the exterior world to our DNA sequence, and it can change dramatically. This episode discusses the state of the art of epigenomics analysis and the epigenome in the context of specific cells. Additionally, it explores the future of epigenomics for individualized medicine and in better understanding genetics of treatment resistance. The guest for this episode is Alexandre Gaspar Maia, Ph.D., an assistant professor in the Functional Genomics Laboratory at Mayo Clinic. Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Host: Edward R. Laskowski, M.D Guest: Anthony A. Stans, M.D. The evaluation and treatment of scoliosis is an area that has created some controversy over the years. Should we be screening kids in school? When do we brace kids with scoliosis? And what are the indications for surgery? To help us answer these questions and more, I am delighted to welcome Anthony A. Stans, M.D., a consultant in the Division of Pediatric Orthopedic Surgery with special interest in the treatment of spinal deformity. He is past Chair of the Mayo Clinic Division of Pediatric Orthopedic Surgery and past Surgeon in Chief for the Mayo Clinic Children’s Center. Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Guest: Bradley F. Boeve, M.D. Host: Denise M. Dupras, M.D., Ph.D. Family history is so important in deciphering genetic causes for neurodegenerative disorders. As we study polygenetic situations, we are learning that often it is not just one gene, but the contribution of multiple genes that lead to the presentation of a patient with cognitive or brain function deterioration that occurs at a variable rate. In this episode, we discuss genes and neurodegenerative brain disease, and our guest is Bradley F. Boeve, M.D., a consultant in the Department of Neurology and the Center for Sleep Medicine, as well as a professor of neurology at the Mayo Clinic in Rochester, Minnesota. Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Host: Darryl S. Chutka, M.D. @chutkaMD Guest: Jason C. Sluzevich, M.D. Psoriasis is a somewhat atypical dermatologic condition which can come and go over time. In many, there may be seasonal effects and in some, psoriasis can have an associated arthritis. It has a characteristic distribution and while it has no cure, there are a variety of established and new treatment options. In this podcast, we’ll review how to diagnose psoriasis, its characteristic appearance, its associated arthritis, and management strategies with Jason C. Sluzevich, M.D., a dermatologist from the Mayo Clinic. Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Guests: Sandhya Pruthi, M.D. (@DrSandhyaPruthi) Host: Denise M. Dupras, M.D., Ph.D. What is precision prevention? As providers, what can we do to best determine who is at high risk for breast cancer, and when to make appropriate decisions about interventions to reduce an individual’s risk for getting breast cancer? In this episode of our Genes & Your Health edition from the Center for Individualized Medicine, we will learn more about breast cancer, breast cancer genes and the role of single nucleotide polymorphisms (SNPs) in breast cancer risk assessment. Our guest is Sandhya Pruthi, M.D., a Mayo Clinic physician in breast disease and a consultant and Professor of Medicine in the Department of General Internal Medicine in Rochester, Minnesota. Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Host: Darryl S. Chutka, M.D. @ChutkaMD Guest: Stephen Kopecky, M.D. Most of us want to live longer, but we want to live a healthy life and avoid the many health problems associated with growing older. Many of the health issues associated with aging have significant morbidity and have the potential to significantly affect our quality of life. Do we know how to avoid these health problems and stay healthy into our older ages? What should we be advising our patients to help them live younger longer? We’ll discuss these questions with our guest today, Stephen Kopecky, M.D., a preventive cardiologist at the Mayo Clinic. Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Guest: Fouad T. Chebib, M.D. Host: Denise M. Dupras, M.D., Ph.D. What is polycystic kidney disease? Is it all genetic? As providers, what should we be considering and what patients should we think about screening with genetic testing? Join this episode of our Genes & Your Health edition from the Center for Individualized Medicine to learn more about the role of genes in polycystic kidney disease. This episode features Fouad T. Chebib, M.D., a Mayo Clinic nephrologist from Jacksonville, Florida, whose specialty is in polycystic kidney disease. Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Guest: Konstantinos N. Lazaridis, M.D. Host: Denise M. Dupras, M.D., Ph.D. What does the exposome mean? In this episode, we will define the exposome and explore how assessing exposures in an organized fashion will help us better understand the gene environment interaction. The guest for this episode of our Genes & Your Health edition from the Center for Individualized Medicine is Konstantinos N. Lazaridis, M.D., a Mayo Clinic physician in the Division of Gastroenterology and Hematology, as well as the Bernard and Edith Waterman Director, Microbiome Program, Center for Individualized Medicine and Carlson and Nelson Endowed Director, Center for Individualized Medicine. Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Host: Darryl S. Chutka, M.D. (@ChutkaMD) Guest: Wilson I. Gonsalves, M.D. Monoclonal gammopathies represent abnormal proteins produced by plasma cells. The most common monoclonal gammopathy is monoclonal gammopathy of undetermined significance or MGUS. While MGUS itself is not a malignancy and doesn’t require treatment, patients with MGUS have an increased risk of developing a variety of hematologic malignancies and therefore do require surveillance. The topic for today’s podcast is monoclonal gammopathy of undetermined significance and our guest is Wilson I. Gonsalves, M.D., a hematologist and oncologist from the Division of Hematology at the Mayo Clinic. We’ll discuss how to diagnose MGUS, who is more likely to develop this condition and how patients with it should be followed. Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

This episode is shared from Mayo Clinic Q&A and was recorded on August 31, 2022 Guest: Gregory A. Poland, M.D. (@drgregpoland) Host: Halena M. Gazelka, M.D. (@hmgazelkamd) The first significant change to COVID-19 vaccines since their rollout came this week as the Food and Drug Administration granted emergency use authorization for updated Moderna and Pfizer COVID-19 boosters aimed at the omicron variants. The Centers for Disease Control and Prevention (CDC) also signed off on the recommendation, clearing the way for the new COVID-19 booster to be administered. The new boosters are bivalent vaccines, meaning they target more than one strain of the virus. The new formulation targets the BA.4 and BA.5 omicron variants, in addition to the original coronavirus strain. BA.5 is responsible for nearly 90% of all new COVID-19 cases in the U.S., according to the CDC. The Pfizer bivalent booster is approved for people 12 and up if they have already received their primary COVID-19 vaccine series and it has been at least two months since their last vaccine dose. The Moderna bivalent booster is available on the same timeline to people 18 and up. "This booster recommendation is in anticipation that there will be yet another surge as college students, grade school and high school students are gathering back together," explains Dr. Gregory Poland, head of Mayo Clinic's Vaccine Research Group. "We're also preparing for cooler weather, meaning more indoor activities, family gatherings and the holidays — often without masks, unfortunately. We still need to take COVID seriously." Another big concern for vaccine experts is the upcoming flu season. The Southern Hemisphere is often an indicator of what's to come for the U.S. Australia's flu season exceeded its five-year average, particularly affecting children under age 5, according to a recent report. Experts worry that the relaxing of masking and social distancing recommendations that were in place for COVID-19 purposes the past two winters will be a factor. These measures also protected people from the flu. "When cold weather moves us indoors, a high viral circulation occurs in schools and other indoor settings. I think we are very likely to see a bad flu year," says Dr. Poland. "Now I know we've been predicting that for two years, but for the most part, people wore masks and it didn't happen. I don't think that'll be the case this year. People are not wearing masks, and we are very likely to get hit hard by influenza." On the Mayo Clinic Q&A podcast, Dr. Poland discusses the latest COVID-19 news and touches on other news, including monkeypox, polio and the upcoming flu season.

Host: Joshua D. Luciew, P.A.-C. Guest: Arthur J. De Luigi, D.O., M.H.A. (@DrDeLuigi, https://twitter.com/drdeluigi) Heel and foot pain can be a burdensome symptom for our patients, as discomfort can be experienced with each step they take, hindering locomotion. Many different patient populations are required to be on their feet for their job or for various wellness goals, which can exacerbate their painful heel and foot or deter them from exercise. In this episode, we will explore the most common cause of heel and foot pain: plantar fasciitis. Listeners will learn from a Mayo Clinic specialist in Physical Medicine and Rehabilitation how plantar fasciitis develops, how it is properly diagnosed, and learn the best approaches for treatments of this condition to help patients resume their previous physical activities, pain-free. Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Host: Darryl S. Chutka, M.D. (@ChutkaMD) Guest: Julie A. Khoury, M.D. Peripheral neuropathy is a relatively common neurologic condition we frequently see in primary care. Some patients may describe the symptoms as paresthesias and they represent a minor nuisance, however others may have very painful dysesthesias. Since some peripheral neuropathies are reversible, we need to know when to suspect a peripheral neuropathy, how to evaluate patients who have them and the possible treatment options. We’ll discuss peripheral neuropathies in this podcast with Julie A. Khoury, M.D., a neurologist at the Mayo Clinic in Phoenix, Arizona. Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Host: Darryl S. Chutka, M.D. (@ChutkaMD) Guest: Ivan E. Porter, II M.D. Kidney stones are quite common and represent one of the most common disorders of the urinary system. When symptomatic, stones are relatively easy to diagnose as they tend to cause a very characteristic clinical presentation. While most stones will pass through the urinary system, others will require a variety of treatment options. The topic for today’s podcast is kidney stones and we’ll discuss the diagnosis, management, and prevention of stones with Ivan E. Porter, II M.D., a nephrologist at the Mayo Clinic. Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Guest: Sandra J. Taler, M.D. Host: Darryl S. Chutka, M.D. (@ChutkaMD) It’s estimated that over 70% of those 65 and older have hypertension and there’s good evidence to show that less than half of these elderly individuals are adequately controlled. While there are many similarities between hypertension in the elderly and the general population, there are also some important differences. The elderly are more likely to have systolic hypertension, take multiple medications and they’re more likely to experience more frequent and serious adverse drug reactions. In this podcast, we’ll learn more about hypertension in the elderly from Sandra J. Taler, M.D., a nephrologist and hypertension specialist at the Mayo Clinic in Rochester, Minnesota. Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Host: Sanjeev (Sanj) Kakar, M.D. (sanjkakar) Guest: William W. Cross, III, M.D. (@WilliamCross3MD) Did you know the lifetime prevalence of generalized low back pain is estimated at 60% to 70% in industrialized countries? Often overlooked, the sacroiliac or SI joint can cause approximately one third of these cases. How do you determine the difference between the two? In this week’s podcast, we discuss the diagnosis of SI joint dysfunction and the different modalities for treatment, including non-operative and surgical management with William W. Cross, M.D., an Associate Professor in the Department of Orthopedic Surgery at Mayo Clinic in Rochester, Minnesota. Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. Resource: Sacroiliac Joint Clinic in Minnesota - Overview - Mayo Clinic

To claim credit for this episode, visit Mayo Clinic Talks Podcast: Headache Edition - Online CME Course. Guest: Mark A. Whealy, M.D. Host: Darryl S. Chutka, M.D. (@ChutkaMD) Headache disorders are extremely common, and patients frequently seek our help in the outpatient setting regarding management of their headaches. On occasion, they may present to the emergency department for more severe or prolonged headaches. With this podcast, we will continue our series on headaches as we discuss intractable migraine, also known as status migrainosus. We’ll also discuss other headaches commonly seen in the emergency department. How serious is status migrainosus? How should patients with these headaches be evaluated and what are the most effective management strategies? We’ll discuss these questions with Mark A. Whealy, M.D., a neurologist and headache specialist at the Mayo Clinic. Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.